10x Genomics has received a consensus rating of Buy. See what's happening in the market right now with MarketBeat's real-time news feed.

View which stocks are hot on social media with MarketBeat's trending stocks report. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Sinai and Spain’s Centro Nacional de Análisis Genómico.

(Add your “outperform” vote. The firm's revenue was down 23.1% on a year-over-year basis. View all competitors. On average, they anticipate 10x Genomics' share price to reach $107.63 in the next year. 10x Genomics' management team includes the following people: Co-Founder, Pres, Chief Scientific Officer & Director, Start Your Risk-Free Trial Subscription Here, Applied Materials (NASDAQ: AMAT) Stock is a Core Holdings Buy, Asana (NYSE:ASAN) Stock IPO: 3 Things for Investors to Know, A Buying Opportunity Is Brewing For Starbucks (NASDAQ:SBUX), Conagra Brands (NYSE:CAG) Is A Must-Buy For Dividend Growth Investors, Shopify (NYSE: SHOP) Has Plenty Of Room To Run, Unsure How to Play the Pandemic?

6 September Healthcare IPOs Investors Should Take …

“By introducing the first solution that captures ATAC and gene expression simultaneously, researchers can gain even more clarity by combining two already powerful methods to profile biological systems at single cell resolution simultaneously for the first time.”.

Since then, TXG shares have increased by 104.5% and is now trading at $124.28.

10x Genomics to Participate in the UBS Genomics 2.0 and Medtech Innovations Summit July 14, 2020 10x Genomics Launches Next Generation Immune Profiling Product to Combat COVID-19 Buy the 'GERM' ETF, Target (NYSE: TGT) is Expanding Deal Season and Taking on Amazon. Vote “Outperform” if you believe TXG will outperform the S&P 500 over the long term. About 10x Genomics10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. 10x Genomics started at buy with $62 stock price target at BofA Merrill Lynch Oct. 7, 2019 at 9:48 a.m.

Do Not Sell My Information. Identify stocks that meet your criteria using seven unique stock screeners. 10x Genomics has only been the subject of 4 research reports in the past 90 days. 10x Genomics does not currently pay a dividend. According to analysts' consensus price target of $107.63, 10x Genomics has a forecasted downside of 14.9% from its current price of $126.47. “We plan to use 10x Genomics' new assay to understand the epigenetic and transcriptional regulation of immune cell dysfunction directly in patient samples, and to use this information to precisely engineer more effective immunotherapies in the future.”, “Until now, we have relied on computational prediction to match a cell's epigenome to a single-cell gene expression profile,” said Dr. Holger Heyn, leader of the single cell genomics team at Spain’s Centro Nacional de Análisis Genómico that is working on delineating the dynamics underlying B-cell differentiation and activation. View our earnings forecast for 10x Genomics. This suggests that the stock has a possible downside of 14.9%.

© 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Yahoo ist Teil von Verizon Media.

Export data to Excel for your own analysis.

To learn more, visit https://www.10xgenomics.com/products/single-cell-multiome-atac-plus-gene-expression. Wir und unsere Partner nutzen Cookies und ähnliche Technik, um Daten auf Ihrem Gerät zu speichern und/oder darauf zuzugreifen, für folgende Zwecke: um personalisierte Werbung und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr über die Zielgruppe zu erfahren sowie für die Entwicklung von Produkten. 10x Genomics has received 39 “outperform” votes.

Sign-up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter.

10x Genomics' stock was trading at $60.76 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). 10x Genomics Acquires Epinomics July 31, 2018 10x Genomics Partners with BioLegend and Immudex to Extend Research Applications of Its New Single Cell Feature Barcoding Technology

Learn about financial terms, types of investments, trading strategies and more. Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu.'

10x Genomics has a market capitalization of $12.69 billion. View analyst ratings for 10x Genomics. Find the latest news headlines from 10x Genomics, Inc. Class A Common Stock (TXG) at Nasdaq.com.

The firm had revenue of $42.90 million for the quarter, compared to analysts' expectations of $30.58 million.

Early customers already working with Chromium Single Cell Multiome ATAC + Gene Expression include Stanford University School of Medicine, Icahn School of Medicine at Mt. These forward-looking statements should not be relied upon as representing 10x Genomics, Inc.’s views as of any date subsequent to the date of this press release. The company serves researchers in approximately 40 countries. © American Consumer News, LLC dba MarketBeat® 2010-2020. Looking for new stock ideas?

Learn everything you need to know about successful options trading with this three-part video course.

One share of TXG stock can currently be purchased for approximately $126.47. Based on aggregate information from My MarketBeat watchlists, some companies that other 10x Genomics investors own include NVIDIA (NVDA), Alibaba Group (BABA), QUALCOMM (QCOM), salesforce.com (CRM), Docusign (DOCU), Tesla (TSLA), Advanced Micro Devices (AMD), Splunk (SPLK), Trade Desk (TTD) and Square (SQ).

Receive a free world-class investing education from MarketBeat.

10x Genomics is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020. The company can be reached via phone at 925-401-7300.

10x Genomics Announces Closing of Public Offering and Full Exercise of the Un.. 10x Genomics First to Market With Product to Simultaneously Capture Epigenome.. 10x Genomics Announces Pricing of Upsized Public Offering, 10x Genomics Announces Launch of a Follow-On Public Offering, 10x Genomics to Participate in the Morgan Stanley 2020 Healthcare Conference, President, Chief Scientific Officer & Director, Deepen their characterization of cell types and states with linked transcriptional and epigenomic analyses, Discover cells with similar transcriptional profiles but functionally different chromatin landscapes, Combine discovery of regulatory elements with gene expression to explore gene regulatory interactions driving cell differentiation, development, and disease, Easily interpret epigenetic profiles with key expression markers, Maximize insights from precious samples with multiple readouts from the same cell. Read More Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. 10X Genomics, Inc. was formerly known as 10X Technologies, Inc. and changed its name to 10X Genomics, Inc. in November 2014. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology.

8 brokerages have issued 12-month price targets for 10x Genomics' shares. In the past three months, 10x Genomics insiders have sold more of their company's stock than they have bought.

Get 10X Genomics Inc (TXG:NASDAQ) real-time stock quotes, news and financial information from CNBC.

These and additional risks and uncertainties that could affect 10x Genomics, Inc.’s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" and elsewhere in the documents 10x Genomics, Inc. files with the Securities and Exchange Commission from time to time. 10x Genomics does not have a long track record of dividend growth. The company was incorporated in 2012 and is based in Pleasanton, California. Disclosure Information10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Please log in to your account or sign up in order to add this asset to your watchlist. 10x Genomics employs 500 workers across the globe. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The official website for 10x Genomics is www.10xgenomics.com. PLEASANTON, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it has begun shipping its Chromium Single Cell Multiome ATAC + Gene Expression solution to customers, marking the first commercial release of a product capable of simultaneously profiling the epigenome and transcriptome from the same single cell.

Dies geschieht in Ihren Datenschutzeinstellungen.

Geraldine Viswanathan Blockers, Black History Party, 5k Walks Near Me 2019, Barreleye Acnh, Cleene Cotton Pads Price, Animal Crossing Penguin, New Jack Wrestler Wife, Breast Cancer Pins Australia, Musée Des Beaux-arts, Clone Pikachu Pokémon Go Difference, Beautiful Black Actresses, The Journal Of Negro History Summary, American Eel Fishing, Cotton Bolls Or Balls, Lucky Louie Netflix, Heerema Sleipnir, Persona Q: Shadow Of The Labyrinth Review, Martha Gellhorn Vietnam War Articles, Brawler Definition, Kasper Philadelphia Union, Vàli Band, Association Studies Vs Linkage Analysis, China Military Parade 2020, Dugtrio Evolution, David Icke Vimeo, Dusclops Competitive Moveset, Wga East Dues, The Nature Of Prejudice Amazon, How To Read Because The Internet Screenplay, Ccim Cost, How To Get Into A Capped Major Ucsd, Buizel Serebii, The Establishment Meaning, Pink Friday Perfume, Monado Replica Ex Future Connected, Lunatone Pokémon Go Location, Chile Civil War Today, Top 20 South Park Characters, Never Meet Your Heroes Lyrics, Cartilaginous Fish Vs Bony Fish, How To Move In Pokemon Go Without Walking 2019, Sorbothane Feet, Cordelia Nickname, Pap Smear Results, Muses Names, Mj Hegar, Mj Hegar Awards, Where Was Mathieu Da Costa Born, B-wing Star Wars, Integrating Red Hat Enterprise Linux 7 With Active Directory, Ryoma Danganronpa, Genetic Engineering, Riki Dota 1, Pumped Up Kicks Chords No Capo, Akala Family, Riju Botw Height, Selma City Schools Salary Matrix, At What Barometric Pressure Does It Rain, Damn Urban Dictionary, Terry Bogard Hat, How To Make A Qtip Election On Form 706, Extra Large Cotton Wool Balls, Tie Fighter Minecraft, Breast Cancer Ribbon Tattoo With Wings, Colditz Tv Series Cast, Terry Hollands, Pholus Astrology Calculator, " />

10x Genomics has received a consensus rating of Buy. See what's happening in the market right now with MarketBeat's real-time news feed.

View which stocks are hot on social media with MarketBeat's trending stocks report. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Sinai and Spain’s Centro Nacional de Análisis Genómico.

(Add your “outperform” vote. The firm's revenue was down 23.1% on a year-over-year basis. View all competitors. On average, they anticipate 10x Genomics' share price to reach $107.63 in the next year. 10x Genomics' management team includes the following people: Co-Founder, Pres, Chief Scientific Officer & Director, Start Your Risk-Free Trial Subscription Here, Applied Materials (NASDAQ: AMAT) Stock is a Core Holdings Buy, Asana (NYSE:ASAN) Stock IPO: 3 Things for Investors to Know, A Buying Opportunity Is Brewing For Starbucks (NASDAQ:SBUX), Conagra Brands (NYSE:CAG) Is A Must-Buy For Dividend Growth Investors, Shopify (NYSE: SHOP) Has Plenty Of Room To Run, Unsure How to Play the Pandemic?

6 September Healthcare IPOs Investors Should Take …

“By introducing the first solution that captures ATAC and gene expression simultaneously, researchers can gain even more clarity by combining two already powerful methods to profile biological systems at single cell resolution simultaneously for the first time.”.

Since then, TXG shares have increased by 104.5% and is now trading at $124.28.

10x Genomics to Participate in the UBS Genomics 2.0 and Medtech Innovations Summit July 14, 2020 10x Genomics Launches Next Generation Immune Profiling Product to Combat COVID-19 Buy the 'GERM' ETF, Target (NYSE: TGT) is Expanding Deal Season and Taking on Amazon. Vote “Outperform” if you believe TXG will outperform the S&P 500 over the long term. About 10x Genomics10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. 10x Genomics started at buy with $62 stock price target at BofA Merrill Lynch Oct. 7, 2019 at 9:48 a.m.

Do Not Sell My Information. Identify stocks that meet your criteria using seven unique stock screeners. 10x Genomics has only been the subject of 4 research reports in the past 90 days. 10x Genomics does not currently pay a dividend. According to analysts' consensus price target of $107.63, 10x Genomics has a forecasted downside of 14.9% from its current price of $126.47. “We plan to use 10x Genomics' new assay to understand the epigenetic and transcriptional regulation of immune cell dysfunction directly in patient samples, and to use this information to precisely engineer more effective immunotherapies in the future.”, “Until now, we have relied on computational prediction to match a cell's epigenome to a single-cell gene expression profile,” said Dr. Holger Heyn, leader of the single cell genomics team at Spain’s Centro Nacional de Análisis Genómico that is working on delineating the dynamics underlying B-cell differentiation and activation. View our earnings forecast for 10x Genomics. This suggests that the stock has a possible downside of 14.9%.

© 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Yahoo ist Teil von Verizon Media.

Export data to Excel for your own analysis.

To learn more, visit https://www.10xgenomics.com/products/single-cell-multiome-atac-plus-gene-expression. Wir und unsere Partner nutzen Cookies und ähnliche Technik, um Daten auf Ihrem Gerät zu speichern und/oder darauf zuzugreifen, für folgende Zwecke: um personalisierte Werbung und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr über die Zielgruppe zu erfahren sowie für die Entwicklung von Produkten. 10x Genomics has received 39 “outperform” votes.

Sign-up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter.

10x Genomics' stock was trading at $60.76 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). 10x Genomics Acquires Epinomics July 31, 2018 10x Genomics Partners with BioLegend and Immudex to Extend Research Applications of Its New Single Cell Feature Barcoding Technology

Learn about financial terms, types of investments, trading strategies and more. Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu.'

10x Genomics has a market capitalization of $12.69 billion. View analyst ratings for 10x Genomics. Find the latest news headlines from 10x Genomics, Inc. Class A Common Stock (TXG) at Nasdaq.com.

The firm had revenue of $42.90 million for the quarter, compared to analysts' expectations of $30.58 million.

Early customers already working with Chromium Single Cell Multiome ATAC + Gene Expression include Stanford University School of Medicine, Icahn School of Medicine at Mt. These forward-looking statements should not be relied upon as representing 10x Genomics, Inc.’s views as of any date subsequent to the date of this press release. The company serves researchers in approximately 40 countries. © American Consumer News, LLC dba MarketBeat® 2010-2020. Looking for new stock ideas?

Learn everything you need to know about successful options trading with this three-part video course.

One share of TXG stock can currently be purchased for approximately $126.47. Based on aggregate information from My MarketBeat watchlists, some companies that other 10x Genomics investors own include NVIDIA (NVDA), Alibaba Group (BABA), QUALCOMM (QCOM), salesforce.com (CRM), Docusign (DOCU), Tesla (TSLA), Advanced Micro Devices (AMD), Splunk (SPLK), Trade Desk (TTD) and Square (SQ).

Receive a free world-class investing education from MarketBeat.

10x Genomics is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020. The company can be reached via phone at 925-401-7300.

10x Genomics Announces Closing of Public Offering and Full Exercise of the Un.. 10x Genomics First to Market With Product to Simultaneously Capture Epigenome.. 10x Genomics Announces Pricing of Upsized Public Offering, 10x Genomics Announces Launch of a Follow-On Public Offering, 10x Genomics to Participate in the Morgan Stanley 2020 Healthcare Conference, President, Chief Scientific Officer & Director, Deepen their characterization of cell types and states with linked transcriptional and epigenomic analyses, Discover cells with similar transcriptional profiles but functionally different chromatin landscapes, Combine discovery of regulatory elements with gene expression to explore gene regulatory interactions driving cell differentiation, development, and disease, Easily interpret epigenetic profiles with key expression markers, Maximize insights from precious samples with multiple readouts from the same cell. Read More Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. 10X Genomics, Inc. was formerly known as 10X Technologies, Inc. and changed its name to 10X Genomics, Inc. in November 2014. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology.

8 brokerages have issued 12-month price targets for 10x Genomics' shares. In the past three months, 10x Genomics insiders have sold more of their company's stock than they have bought.

Get 10X Genomics Inc (TXG:NASDAQ) real-time stock quotes, news and financial information from CNBC.

These and additional risks and uncertainties that could affect 10x Genomics, Inc.’s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" and elsewhere in the documents 10x Genomics, Inc. files with the Securities and Exchange Commission from time to time. 10x Genomics does not have a long track record of dividend growth. The company was incorporated in 2012 and is based in Pleasanton, California. Disclosure Information10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Please log in to your account or sign up in order to add this asset to your watchlist. 10x Genomics employs 500 workers across the globe. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The official website for 10x Genomics is www.10xgenomics.com. PLEASANTON, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it has begun shipping its Chromium Single Cell Multiome ATAC + Gene Expression solution to customers, marking the first commercial release of a product capable of simultaneously profiling the epigenome and transcriptome from the same single cell.

Dies geschieht in Ihren Datenschutzeinstellungen.

Geraldine Viswanathan Blockers, Black History Party, 5k Walks Near Me 2019, Barreleye Acnh, Cleene Cotton Pads Price, Animal Crossing Penguin, New Jack Wrestler Wife, Breast Cancer Pins Australia, Musée Des Beaux-arts, Clone Pikachu Pokémon Go Difference, Beautiful Black Actresses, The Journal Of Negro History Summary, American Eel Fishing, Cotton Bolls Or Balls, Lucky Louie Netflix, Heerema Sleipnir, Persona Q: Shadow Of The Labyrinth Review, Martha Gellhorn Vietnam War Articles, Brawler Definition, Kasper Philadelphia Union, Vàli Band, Association Studies Vs Linkage Analysis, China Military Parade 2020, Dugtrio Evolution, David Icke Vimeo, Dusclops Competitive Moveset, Wga East Dues, The Nature Of Prejudice Amazon, How To Read Because The Internet Screenplay, Ccim Cost, How To Get Into A Capped Major Ucsd, Buizel Serebii, The Establishment Meaning, Pink Friday Perfume, Monado Replica Ex Future Connected, Lunatone Pokémon Go Location, Chile Civil War Today, Top 20 South Park Characters, Never Meet Your Heroes Lyrics, Cartilaginous Fish Vs Bony Fish, How To Move In Pokemon Go Without Walking 2019, Sorbothane Feet, Cordelia Nickname, Pap Smear Results, Muses Names, Mj Hegar, Mj Hegar Awards, Where Was Mathieu Da Costa Born, B-wing Star Wars, Integrating Red Hat Enterprise Linux 7 With Active Directory, Ryoma Danganronpa, Genetic Engineering, Riki Dota 1, Pumped Up Kicks Chords No Capo, Akala Family, Riju Botw Height, Selma City Schools Salary Matrix, At What Barometric Pressure Does It Rain, Damn Urban Dictionary, Terry Bogard Hat, How To Make A Qtip Election On Form 706, Extra Large Cotton Wool Balls, Tie Fighter Minecraft, Breast Cancer Ribbon Tattoo With Wings, Colditz Tv Series Cast, Terry Hollands, Pholus Astrology Calculator, " />

10x genomics stock news

The new solution builds on an array of new products launched by the company this year for both its Chromium platform for single cell analysis as well as its Visium platform for spatial genomics.

Toll Brothers (NYSE: TOL) Stock: Is the Luxury Homebuilder a Buy?

7 Stocks That Could Provide a Year-End Rally, 8 Stocks That Robinhood Investors Got Right, 7 Stocks That Will Help You Forget About the Fed, 7 Stocks That Don’t Care Who Wins the Election, 7 Semiconductor Stocks to Power Your Portfolio, 7 Gold Stocks to Buy Before the Fed Changes Its Mind, 8 Consumer Staples Stocks That Offer Good Value, 6 Stocks Riding the Coattails of Nikola Motor, Receive Analysts' Upgrades and Downgrades Daily. The company reported ($0.41) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.59) by $0.18. PLEASANTON, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (NASDAQ: TXG) (the “Company”) today announced the closing of its public offering of 4,600,000 shares of its Class A … Their forecasts range from $62.00 to $140.00. View analysts' price targets for 10x Genomics.

10x Genomics (NYSE:TXG) posted its quarterly earnings results on Tuesday, August, 11th.

It offers chromium instruments, enzymes, reagents, microfluidic chips, and other consumable products, as well as software for analyzing biological systems. Vote “Underperform” if you believe TXG will underperform the S&P 500 over the long term. Want to see which stocks are moving?

Get daily stock ideas top-performing Wall Street analysts. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist.

“This is one of our most ambitious undertakings at the company,” said Ben Hindson, co-founder and Chief Scientific Officer of 10x Genomics. The company’s patent portfolio comprises more than 775 issued patents and patent applications. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings.

Learn more. 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 10x Genomics in the last year. (TXG) raised $297 million in an initial public offering (IPO) on Thursday, September 12th 2019.

10x Genomics has received a consensus rating of Buy. See what's happening in the market right now with MarketBeat's real-time news feed.

View which stocks are hot on social media with MarketBeat's trending stocks report. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Sinai and Spain’s Centro Nacional de Análisis Genómico.

(Add your “outperform” vote. The firm's revenue was down 23.1% on a year-over-year basis. View all competitors. On average, they anticipate 10x Genomics' share price to reach $107.63 in the next year. 10x Genomics' management team includes the following people: Co-Founder, Pres, Chief Scientific Officer & Director, Start Your Risk-Free Trial Subscription Here, Applied Materials (NASDAQ: AMAT) Stock is a Core Holdings Buy, Asana (NYSE:ASAN) Stock IPO: 3 Things for Investors to Know, A Buying Opportunity Is Brewing For Starbucks (NASDAQ:SBUX), Conagra Brands (NYSE:CAG) Is A Must-Buy For Dividend Growth Investors, Shopify (NYSE: SHOP) Has Plenty Of Room To Run, Unsure How to Play the Pandemic?

6 September Healthcare IPOs Investors Should Take …

“By introducing the first solution that captures ATAC and gene expression simultaneously, researchers can gain even more clarity by combining two already powerful methods to profile biological systems at single cell resolution simultaneously for the first time.”.

Since then, TXG shares have increased by 104.5% and is now trading at $124.28.

10x Genomics to Participate in the UBS Genomics 2.0 and Medtech Innovations Summit July 14, 2020 10x Genomics Launches Next Generation Immune Profiling Product to Combat COVID-19 Buy the 'GERM' ETF, Target (NYSE: TGT) is Expanding Deal Season and Taking on Amazon. Vote “Outperform” if you believe TXG will outperform the S&P 500 over the long term. About 10x Genomics10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. 10x Genomics started at buy with $62 stock price target at BofA Merrill Lynch Oct. 7, 2019 at 9:48 a.m.

Do Not Sell My Information. Identify stocks that meet your criteria using seven unique stock screeners. 10x Genomics has only been the subject of 4 research reports in the past 90 days. 10x Genomics does not currently pay a dividend. According to analysts' consensus price target of $107.63, 10x Genomics has a forecasted downside of 14.9% from its current price of $126.47. “We plan to use 10x Genomics' new assay to understand the epigenetic and transcriptional regulation of immune cell dysfunction directly in patient samples, and to use this information to precisely engineer more effective immunotherapies in the future.”, “Until now, we have relied on computational prediction to match a cell's epigenome to a single-cell gene expression profile,” said Dr. Holger Heyn, leader of the single cell genomics team at Spain’s Centro Nacional de Análisis Genómico that is working on delineating the dynamics underlying B-cell differentiation and activation. View our earnings forecast for 10x Genomics. This suggests that the stock has a possible downside of 14.9%.

© 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Yahoo ist Teil von Verizon Media.

Export data to Excel for your own analysis.

To learn more, visit https://www.10xgenomics.com/products/single-cell-multiome-atac-plus-gene-expression. Wir und unsere Partner nutzen Cookies und ähnliche Technik, um Daten auf Ihrem Gerät zu speichern und/oder darauf zuzugreifen, für folgende Zwecke: um personalisierte Werbung und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr über die Zielgruppe zu erfahren sowie für die Entwicklung von Produkten. 10x Genomics has received 39 “outperform” votes.

Sign-up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter.

10x Genomics' stock was trading at $60.76 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). 10x Genomics Acquires Epinomics July 31, 2018 10x Genomics Partners with BioLegend and Immudex to Extend Research Applications of Its New Single Cell Feature Barcoding Technology

Learn about financial terms, types of investments, trading strategies and more. Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu.'

10x Genomics has a market capitalization of $12.69 billion. View analyst ratings for 10x Genomics. Find the latest news headlines from 10x Genomics, Inc. Class A Common Stock (TXG) at Nasdaq.com.

The firm had revenue of $42.90 million for the quarter, compared to analysts' expectations of $30.58 million.

Early customers already working with Chromium Single Cell Multiome ATAC + Gene Expression include Stanford University School of Medicine, Icahn School of Medicine at Mt. These forward-looking statements should not be relied upon as representing 10x Genomics, Inc.’s views as of any date subsequent to the date of this press release. The company serves researchers in approximately 40 countries. © American Consumer News, LLC dba MarketBeat® 2010-2020. Looking for new stock ideas?

Learn everything you need to know about successful options trading with this three-part video course.

One share of TXG stock can currently be purchased for approximately $126.47. Based on aggregate information from My MarketBeat watchlists, some companies that other 10x Genomics investors own include NVIDIA (NVDA), Alibaba Group (BABA), QUALCOMM (QCOM), salesforce.com (CRM), Docusign (DOCU), Tesla (TSLA), Advanced Micro Devices (AMD), Splunk (SPLK), Trade Desk (TTD) and Square (SQ).

Receive a free world-class investing education from MarketBeat.

10x Genomics is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020. The company can be reached via phone at 925-401-7300.

10x Genomics Announces Closing of Public Offering and Full Exercise of the Un.. 10x Genomics First to Market With Product to Simultaneously Capture Epigenome.. 10x Genomics Announces Pricing of Upsized Public Offering, 10x Genomics Announces Launch of a Follow-On Public Offering, 10x Genomics to Participate in the Morgan Stanley 2020 Healthcare Conference, President, Chief Scientific Officer & Director, Deepen their characterization of cell types and states with linked transcriptional and epigenomic analyses, Discover cells with similar transcriptional profiles but functionally different chromatin landscapes, Combine discovery of regulatory elements with gene expression to explore gene regulatory interactions driving cell differentiation, development, and disease, Easily interpret epigenetic profiles with key expression markers, Maximize insights from precious samples with multiple readouts from the same cell. Read More Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. 10X Genomics, Inc. was formerly known as 10X Technologies, Inc. and changed its name to 10X Genomics, Inc. in November 2014. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology.

8 brokerages have issued 12-month price targets for 10x Genomics' shares. In the past three months, 10x Genomics insiders have sold more of their company's stock than they have bought.

Get 10X Genomics Inc (TXG:NASDAQ) real-time stock quotes, news and financial information from CNBC.

These and additional risks and uncertainties that could affect 10x Genomics, Inc.’s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" and elsewhere in the documents 10x Genomics, Inc. files with the Securities and Exchange Commission from time to time. 10x Genomics does not have a long track record of dividend growth. The company was incorporated in 2012 and is based in Pleasanton, California. Disclosure Information10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Please log in to your account or sign up in order to add this asset to your watchlist. 10x Genomics employs 500 workers across the globe. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The official website for 10x Genomics is www.10xgenomics.com. PLEASANTON, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it has begun shipping its Chromium Single Cell Multiome ATAC + Gene Expression solution to customers, marking the first commercial release of a product capable of simultaneously profiling the epigenome and transcriptome from the same single cell.

Dies geschieht in Ihren Datenschutzeinstellungen.

Geraldine Viswanathan Blockers, Black History Party, 5k Walks Near Me 2019, Barreleye Acnh, Cleene Cotton Pads Price, Animal Crossing Penguin, New Jack Wrestler Wife, Breast Cancer Pins Australia, Musée Des Beaux-arts, Clone Pikachu Pokémon Go Difference, Beautiful Black Actresses, The Journal Of Negro History Summary, American Eel Fishing, Cotton Bolls Or Balls, Lucky Louie Netflix, Heerema Sleipnir, Persona Q: Shadow Of The Labyrinth Review, Martha Gellhorn Vietnam War Articles, Brawler Definition, Kasper Philadelphia Union, Vàli Band, Association Studies Vs Linkage Analysis, China Military Parade 2020, Dugtrio Evolution, David Icke Vimeo, Dusclops Competitive Moveset, Wga East Dues, The Nature Of Prejudice Amazon, How To Read Because The Internet Screenplay, Ccim Cost, How To Get Into A Capped Major Ucsd, Buizel Serebii, The Establishment Meaning, Pink Friday Perfume, Monado Replica Ex Future Connected, Lunatone Pokémon Go Location, Chile Civil War Today, Top 20 South Park Characters, Never Meet Your Heroes Lyrics, Cartilaginous Fish Vs Bony Fish, How To Move In Pokemon Go Without Walking 2019, Sorbothane Feet, Cordelia Nickname, Pap Smear Results, Muses Names, Mj Hegar, Mj Hegar Awards, Where Was Mathieu Da Costa Born, B-wing Star Wars, Integrating Red Hat Enterprise Linux 7 With Active Directory, Ryoma Danganronpa, Genetic Engineering, Riki Dota 1, Pumped Up Kicks Chords No Capo, Akala Family, Riju Botw Height, Selma City Schools Salary Matrix, At What Barometric Pressure Does It Rain, Damn Urban Dictionary, Terry Bogard Hat, How To Make A Qtip Election On Form 706, Extra Large Cotton Wool Balls, Tie Fighter Minecraft, Breast Cancer Ribbon Tattoo With Wings, Colditz Tv Series Cast, Terry Hollands, Pholus Astrology Calculator,

Leave a Reply

Your email address will not be published. Required fields are marked *